Cytosorbents (CTSO) Tops Q1 EPS by 2c
Get Alerts CTSO Hot Sheet
Join SI Premium – FREE
Cytosorbents (NASDAQ: CTSO) reported Q1 EPS of ($0.08), $0.02 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $1.8 million versus the consensus estimate of $1.69 million.
For earnings history and earnings-related data on Cytosorbents (CTSO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SLM (SLM) Misses Q2 EPS by 16c; offers guidance
- BayCom Corp (BCML) Misses Q2 EPS by 128c
- First Resource Bank (FRSB) Tops Q2 EPS by 92c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share